Showing results (601-610 of 639) with videos related to
Sort By:
Pageof 64
Neurology|June 27, 2025
Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation StudyScott C Zimmerman, Minhyuk Choi, Chen Jiang, et al.Microbiology Resource Announcements|April 11, 2020
Draft Genome Sequence of Yokenella regensburgei Strain WCD67, Isolated from the Boxelder BugDesiree J Meyers, Brittany A Leigh, Marcel Huntemann, et al.Neurology|October 4, 2023
Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care PlanErin L Ferguson, Scott C Zimmerman, Chen Jiang, et al.Msphere|September 13, 2019
Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosisGregory A Harrison, Anne E Mayer Bridwell, Megh Singh, et al.ACS Omega|April 5, 2021
Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformansJeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, et al.European Journal of Epidemiology|May 3, 2025
Uncertainty in the estimated effects of statin initiation on risk of dementia: using a multiverse analysis to assess sources of variabilityErin L Ferguson, Scott C Zimmerman, Chen Jiang, et al.Antimicrobial Agents and Chemotherapy|December 3, 2014
Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activityGaofeng Lu, Elena Lomonosova, Xiaohong Cheng, et al.Cancer Journal (Sudbury, Mass.)|November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in CaliforniaCynthia L Martel, Yueju Li, Laurel Beckett, et al.Health Affairs (Project Hope)|March 8, 2017
Synthesis Of Research On Patient-Centered Medical Homes Brings Systematic Differences Into ReliefAnna D Sinaiko, Mary Beth Landrum, David J Meyers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.Pageof 64